HIGHLIGHTS
- who: Huayu Yang from the University of Burdwan, India have published the Article: Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma, in the Journal: (JOURNAL)
- what: The authors report a case of TEN a rare toxicity induced by anti-PD-1 sintilimab in an elderly patient with thymic carcinoma.
SUMMARY
Thymic carcinoma, immunotherapy, sintilimab, immune-related adverse events, toxic epidermal necrolysis Case report Six years ago, he was diagnosed with thymic squamous cell carcinoma with pericardial metastases. His laboratory parameters were as follows: leukocyte . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.